CDC Website CDC Website

To Join the NPIN community or

You are here

Home

HIV

Selected National HIV Prevention and Care Outcomes Slideset

The slide set provides graphical representations of some of the care outcome data in the report, Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data – United States and 6 Dependent Areas, 2015.

Understanding the HIV Care Continuum

This information sheet explains the various approaches and data used to develop the HIV care continuum, how it is used to improve outcomes for people living with HIV in the United States and how it helps guide the nation’s response to HIV.

HIV/AIDS in the United States: The Basics

This information sheet provides key facts and an overview on the current state of HIV/AIDS in the United States. The fact sheet also provides information on the impact of HIV across the country, impact on racial and ethnic minorities, women, young people, and gay and bisexual men. Information is also provided on the U.S. government response in the battle to combat HIV.

Implementing Evidence-Based Prevention Interventions for Key and Priority Populations in the Republic of Rwanda under the President's Emergency Plan for AIDS Relief (PEPFAR)

The intent of this NOFO is to build on the previous work in implementing evidence-based interventions for HIV prevention, care, and treatment among key populations (KP) and priority populations (PP) in Rwanda including male and female commercial sexual workers (CSWs), men who have sex with men (MSM), and other high-risk individuals.

Develop, Implement, and Sustain High Quality Comprehensive HIV Cascade Activities for Children, Adolescents, and Adults in Facility and Community Based Settings in Cameroon under the President`s Emergency Plan for AIDS Relief (PEPFAR)

This award is to support implementation of direct service delivery and technical assistance to regions with large urban areas in Cameroon. The award will support implementation of high quality, evidence-informed case-finding and clinical care services for HIV along the clinical cascade. It will include implementing and supporting the best and most appropriate interventions to reach 90-90-90 across all age groups and populations.

HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies of genotype/phenotype correlations in diverse subtypes, the relationship between drug resistance mutations present in minority variant viral populations and treatment outcomes, and on the reasons for the discordance between genotype and treatment success or failure. Laboratory evaluations of samples with clinical correlates in patients on recommended regimens are encouraged.

Supporting Laboratory Strengthening Activities and Partnerships for Countries Supported under the President's Emergency Plan for AIDS Relief (PEPFAR)

The purpose of this program build and strengthen in-country capacity for sustainable laboratory networks in PEPFAR-supported countries. The program will focus on: 1) workforce develop through enhanced in-service laboratory training and certification programs; 2) continuous quality improvement by strengthening the laboratory standards, policies and systems,; and; 3) increasing laboratory capacity to perform quality laboratory testing for Mycobacterium tuberculosis and other opportunistic infections.

Pages

Subscribe to RSS - HIV